Follow
Esnault Cyril
Esnault Cyril
Data Science Lead, Roche
Verified email at roche.com
Title
Cited by
Cited by
Year
Native plants and nitrogen in agricultural landscapes of New Zealand
HM Franklin, NM Dickinson, CJD Esnault, BH Robinson
Plant and soil 394, 407-420, 2015
362015
Identification of subgroups of patients with type 2 diabetes with differences in renal function preservation, comparing patients receiving sodium‐glucose co‐transporter‐2 …
FL Zhou, H Watada, Y Tajima, M Berthelot, D Kang, C Esnault, Y Shuto, ...
Diabetes, Obesity and Metabolism 21 (8), 1925-1934, 2019
242019
Q-finder: an algorithm for credible subgroup discovery in clinical data analysis—an application to the international diabetes management practice study
C Esnault, ML Gadonna, M Queyrel, A Templier, JD Zucker
Frontiers in artificial intelligence 3, 559927, 2020
172020
G4access identifies G-quadruplexes and their associations with open chromatin and imprinting control regions
C Esnault, T Magat, A Zine El Aabidine, E Garcia-Oliver, A Cucchiarini, ...
Nature genetics 55 (8), 1359-1369, 2023
142023
Qluster: An easy-to-implement generic workflow for robust clustering of health data
C Esnault, M Rollot, P Guilmin, JD Zucker
Frontiers in Artificial Intelligence 5, 1055294, 2023
42023
RNA polymerase II CTD is dispensable for transcription and required for termination in human cells
Y Yahia, A Pigeot, AZ El Aabidine, N Shah, N Karasu, I Forné, S Krebs, ...
EMBO reports 24 (9), e56150, 2023
32023
P1186: A LARGE FRENCH REAL WORLD MULTICENTRIC PROSPECTIVE COHORT OF PATIENTS WITH LYMPHOMA (REALYSA STUDY): DESCRIPTION OF THE DIFFUSE LARGE B CELL LYMPHOMA PATIENTS IN REAL …
H Ghesquieres, F Cherblanc, A Belot, V Camus, K Thokagevistk, ...
Hemasphere 6, 1072-1073, 2022
22022
PDB16-COMPARE RENAL FUNCTIONAL PRSERVATION OUTCOME OF SGLT2 INHIBITOR VS DPP4 INHIBITOR IN PATIENTS WITH TYPE 2 DIABETES: A RETROSPECTIVE COHORT STUDY OF JAPANESE COMMERCIAL …
FL Zhou, H Watada, Y Tajima, M Berthelot, D Kang, C Esnault, Y Shuto, ...
Value in Health 21, S121, 2018
22018
MSR99 Cartography of Biostatistics and Machine Learning Methods to Identify Prognostic Factors
L Mounier, A Civet, J Dupin, D Pau, C Esnault
Value in Health 25 (12), S369, 2022
12022
Limitations and opportunities for identifying outcome prognostic factors in the context of small samples
L Mounier, A Civet, D Pau, J Dupin, C Esnault
Value in Health 25 (12), S375, 2022
1*2022
G-quadruplex forming motifs in the promoter region of the B-MYB proto-oncogene
A Miranda, A Cucchiarini, C Esnault, JC Andrau, PA Oliveira, JL Mergny, ...
International Journal of Biological Macromolecules, 132244, 2024
2024
The long non-coding RNA Meg3 mediates imprinted gene expression during stem cell differentiation
S Farhadova, A Ghousein, F Charon, C Surcis, M Gomez-Velazques, ...
Nucleic Acids Research, gkae247, 2024
2024
Challenges for quality and utilization of real-world data for diffuse large B-cell lymphoma in REALYSA, a LYSA cohort
H Ghesquières, F Cherblanc, A Belot, S Micon, KK Bouabdallah, ...
Blood Advances 8 (2), 296-308, 2024
2024
Impact de la voie d’administration sous-cutanée pour les professionnels de santé, les patients et les organismes payeurs: résultats d’une revue de la littérature
A Groenez, C Esnault, A Gherardi, S Gally, C Tuvi, N Grémaud, S Saget, ...
Revue des Maladies Respiratoires Actualités 16 (1), 272-273, 2024
2024
EE676 Cost Considerations: Exploring the Economic Implications of Choosing SC or IV Administration
A Gherardi, S Gally, A Groenez, C Esnault, K Thokagevistk, S Saget, ...
Value in Health 26 (12), S184, 2023
2023
EPH243 Overview of Lung Cancer Screening Studies in France and Bordering Countries
A Groenez, K Thokagevistk, C Esnault, E Castrec, S Gally, BBH Yahia
Value in Health 26 (12), S247-S248, 2023
2023
RWD102 Cluster Algorithm for Credible Subgroup Identification in Patients with Erectile Dysfunction Receiving Tadalafil: A Real-World Data Study
KT McVary, C Daluwatte, RA Kloner, M Montmerle, M Rollot, P Guilmin, ...
Value in Health 26 (6), S380, 2023
2023
RWD45 Real-World Data to Support Surrogate Endpoint Evaluation for Health Technology Assessment
J Dupin, K Thokagevistk, L Emonnot, S Micon, K Benyounes, D Havet, ...
Value in Health 25 (12), S456-S457, 2022
2022
MSR49 Comparison of Methods for Identifying Genome Profiling Actionability Prognostic Factors in the Context of Small Samples Using a RWD Study
L Mounier, S Galoin, C Esnault, D Pau, J Dupin, A Civet
Value in Health 25 (12), S359, 2022
2022
Comment effectuer des comparaisons indirectes ajustées par appariement (MAIC) avec imputations multiples des données manquantes et dans un contexte de faibles échantillons? Une …
C Esnault, V Barbet, T Filleron, G Chenuc, M Pérol, D Debieuvre, N Girard, ...
Revue d'Épidémiologie et de Santé Publique 70, S266-S267, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20